designed by Fisher Tomlin & Bowyer, please click here for more information
Bowel Disease UK was formed in 2007 as The Colorectal Research Fund but after a few years our name was changed to allow supporters to understand exactly what we did.
We raise much needed and vital funds for direct research into IBD (Inflammatory Bowel Disease) and Bowel Cancer at St George's University Hospital under the guidance of Professor Devinder Kumar, one of the world leading gastrointestinal surgeons and researchers.
All the income generation and administration for the charity is managed without salaried or paid employees allowing a much higher percentage of our income to be directed to our research projects and front line services.
We have held many fundraising events at the House of Commons, Lincoln's Inn, Hampton Court Palace and The All England Club (Wimbledon Tennis) and have raised in excess of £400k since our inception.
We have also funded some amazing research projects, including a £200k donation to St George's University Hospital to study the positive effects of Artesunate in the treatment of Bowel Cancer. Should the next 3 years of clinical trials match the initial 2 year study, then hopefully we would have found a ground breaking treatment for Bowel Cancer, something we would be extremely proud of.
Between 3000 and 6000 cases of Crohn's Disease are diagnosed every year, 1 in 6 of those diagnosed are under the age of 16. Research suggests this disease is caused by genetics and not diet, although we are funding another major research from July 2016, which will investigate DNA and Diet while in remission of Crohn's Disease.
Bowel cancer is curable if detected early, many individuals ignore the bowel testing kits they are given, DON'T, this test could save your life. If you have any unusual bowel movements, pain, bleeding or something else worrying you, speak to your GP as soon as possible.
If you would like to donate to Bowel Disease UK to help us continue our vital work, please see our 'Fundraising' page above.
Thank you in advance, Gary Douch, Chairman